GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 1 339.5 GBX 0.41% Market Closed
Market Cap: 54.7B GBX
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

Wall Street
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 1 706.35 GBX with a low forecast of 1 201.9 GBX and a high forecast of 2 614.5 GBX.

Lowest
Price Target
1 201.9 GBX
10% Downside
Average
Price Target
1 706.35 GBX
27% Upside
Highest
Price Target
2 614.5 GBX
95% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
603998
Hunan Fangsheng Pharmaceutical Co Ltd
41% Upside
13
HUTCHMED (China) Ltd
81% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
31% Upside
002821
Asymchem Laboratories Tianjin Co Ltd
26% Upside
4530
Hisamitsu Pharmaceutical Co Inc
13% Upside
ANCR
Animalcare Group PLC
43% Upside
002399
Shenzhen Hepalink Pharmaceutical Group Co Ltd
33% Downside
300558
Betta Pharmaceuticals Co Ltd
6% Upside

Revenue
Forecast

Revenue Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 3%. The projected CAGR for the next 4 years is 5%.

3%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 7%. The projected CAGR for the next 4 years is 10%.

7%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
GlaxoSmithKline PLC

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -6%. The projected CAGR for the next 4 years is 14%.

-6%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-23%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSK's stock price target?
Price Target
1 706.35 GBX

According to Wall Street analysts, the average 1-year price target for GSK is 1 706.35 GBX with a low forecast of 1 201.9 GBX and a high forecast of 2 614.5 GBX.

What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 3%. The projected CAGR for the next 4 years is 5%.

What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 7%. The projected CAGR for the next 4 years is 10%.

What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for GlaxoSmithKline PLC's net income is -6%. The projected CAGR for the next 4 years is 14%.

Back to Top